arrow
K

Kai Schulze-Forster

celltrend gmbh, im biotechnologiepark 3 tgz ii, 14943 luckenwalde, germany
H指数:19
被引数:1,637

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms

靶向AGTR1的自身抗体失调与新型冠状病毒肺炎症状的积累有关

2025-01-130
OAAI
Protease-Activated Receptor-1 IgG Autoantibodies in Patients with COVID-19

新型冠状病毒肺炎患者的蛋白酶激活受体1 IgG自身抗体

2023-12-291
PRE
Autoantibodies against the chemokine receptor 3 predict cardiovascular risk

针对趋化因子受体3的自身抗体可预测心血管风险

2023-11-066
OAAI
An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line

从哺乳动物悬浮细胞系生产免疫原性SARS CoV-2病毒样颗粒 (VLP) 的有效且可扩展的方法

2023-09-098
OAAI
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
2023-05-0113
PRE
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity
2022-09-2757
OAAI
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
2022-03-0971
OAAI
Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis
2020-09-2813
OAAI
GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis
2018-12-06125
OAAI